Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Published November 23, 2022 · Recall initiated: November 9, 2022
Summary
FDA records drug Class II recall D-0060-2023, published November 23, 2022 and initiated November 9, 2022. Recalling firm: ImprimisRx NJ; Status: Terminated; Reported quantity: 960 bottles; Lot: Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ImprimisRx NJ
- Distributor
- Nationwide in the USA
- Lot
- Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDCNovember 23, 2022
- FDAPhenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par PharmaceuticalNovember 23, 2022
- FDA0.9% Sodium Chloride Injection, USP, 100 mL flexible container bag, Rx Only, ICU Medical, Inc., Lake Forest,November 23, 2022
- FDALa Rosa Brand BluCrab Pasteurized Crabmeat (Jumbo, Lump, Claw) Peso Neto: 454g Can label art is the same forNovember 16, 2022
- FDAChicken Salad Sandwich Club 18 Inch Tray, Black tray with 16 pre-made sandwiches, UPC 2 9615 90000 0,November 16, 2022
- FDATimolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only,August 7, 2019
Questions about this recall
Was Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ. recalled?
Yes. FDA published recall D-0060-2023 on November 23, 2022. Reported hazard: Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
What should I do if I have this product?
Voluntary: Firm initiated · Letter